Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FY.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.212EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.212EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.212ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.212ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.212EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.212EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.212ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.212ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.61EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.61ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.61ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.61EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.61EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used